For: | Oppenheimer AP, Koh C, McLaughlin M, Williamson JC, Norton TD, Laudadio J, Heller T, Kleiner DE, High KP, Morse CG. Vanishing bile duct syndrome in human immunodeficiency virus infected adults: A report of two cases. World J Gastroenterol 2013; 19(1): 115-121 [PMID: 23326172 DOI: 10.3748/wjg.v19.i1.115] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i1/115.htm |
Number | Citing Articles |
1 |
Jessy J. Fadel, Georges M. Bahr, Karim S. Echtay. Absence of effect of the antiretrovirals Duovir and Viraday on mitochondrial bioenergetics. Journal of Cellular Biochemistry 2018; 119(12): 10384 doi: 10.1002/jcb.27384
|
2 |
Angela Shogbon Nwaesei, Pamela M. Moye-Dickerson, Robin Henry Dretler. Efavirenz-Induced Vanishing Bile Duct Syndrome: A Case Report. Journal of Pharmacy Practice 2021; 34(2): 319 doi: 10.1177/0897190019868358
|
3 |
Obeng Laurenda, Patel Anneka, Villa Giovanni, Mourad Adele, Whibley Max, Gilleece Yvonne, Verma Sumita. Autoimmune Hepatitis in People Living with HIV: A Case Series and Review of Literature. The Open AIDS Journal 2023; 17(1) doi: 10.2174/18746136-v17-230825-2023-15
|
4 |
Sorbarikor Piawah, Colby Hyland, Sarah E. Umetsu, Laura J. Esserman, Hope S. Rugo, A. Jo Chien. A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel. npj Breast Cancer 2019; 5(1) doi: 10.1038/s41523-019-0112-z
|
5 |
Sarah Chwiki, Maria Mercedes Campos, Mary E. McLaughlin, David E. Kleiner, Joseph A. Kovacs, Caryn G. Morse, Mones S. Abu-Asab. Adverse effects of antiretroviral therapy on liver hepatocytes and endothelium in HIV patients: An ultrastructural perspective. Ultrastructural Pathology 2017; 41(2): 186 doi: 10.1080/01913123.2017.1282066
|
6 |
Ashraf Abugroun, Ibett Colina Garcia, Fatima Ahmed, Steven Potts, Michael Flicker. The first report of atovaquone/proguanil-induced vanishing bile duct syndrome: Case report and mini-review. Travel Medicine and Infectious Disease 2019; 32: 101439 doi: 10.1016/j.tmaid.2019.06.010
|
7 |
Pengzhi Yu, Yonghe Zhou, Xin Li. Two‐dimensional ultrasonography and CEUS of a case with primary biliary cholangitis and vanishing bile duct syndrome. Journal of Clinical Ultrasound 2022; 50(9): 1368 doi: 10.1002/jcu.23350
|
8 |
C. Cotter, M. Biswas, N. Rao, A Selim, S. Walsh. Vanishing bile duct syndrome with eruptive xanthomas. Clinical and Experimental Dermatology 2020; 45(3): 364 doi: 10.1111/ced.14043
|
9 |
Mark W. Sonderup, Helen Cecilia Wainwright. Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Liver Pathology. Gastroenterology Clinics of North America 2017; 46(2): 327 doi: 10.1016/j.gtc.2017.01.007
|
10 |
Chiyumi Oda, Atsunori Tsuchiya, Atsushi Kimura, Kentaro Tominaga, Kazunao Hayashi, Takashi Ushiki, Hajime Umezu, Shuji Terai. Immunoglobulin therapy for successful management of prolonged, recurrent jaundice in a young adult male with combined immunodeficiency. Clinical Journal of Gastroenterology 2021; 14(4): 1197 doi: 10.1007/s12328-021-01347-0
|
11 |
Antibacterials/valproate semisodium. Reactions Weekly 2014; 1494(1): 9 doi: 10.1007/s40278-014-9677-3
|
12 |
Sarah Banks, Kavita Prabhakar. HIV and GI Tract Complications. Clinical Gastroenterology 2019; : 25 doi: 10.1007/978-3-030-13377-1_3
|
13 |
Ana M. Benedicto, Isabel Fuster-Martínez, Joan Tosca, Juan V. Esplugues, Ana Blas-García, Nadezda Apostolova. NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved. Cells 2021; 10(7): 1687 doi: 10.3390/cells10071687
|
14 |
Hirofumi Fukuda, Yosuke Kondo, Sohji Nishina, Hironobu Ohumi, Yasuyuki Tomiyama, Akihiko Kanki, Hidemitsu Sotozono, Seiya Hashimoto, Harunoshin Yasui, Risa Shimizu, Keisuke Hino, Eisei Kondo, Hideho Wada. A case of successful treatment with antiretroviral therapy for HIV in a patient with marked liver dysfunction. Heliyon 2022; 8(11): e11550 doi: 10.1016/j.heliyon.2022.e11550
|
15 |
Balázs Nemes, György Gámán, Attila Doros. Biliary complications after liver transplantation. Expert Review of Gastroenterology & Hepatology 2015; 9(4): 447 doi: 10.1586/17474124.2015.967761
|